Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.50
VOLC's Cash to Debt is ranked higher than
57% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 1.73 vs. VOLC: 0.50 )
VOLC' s 10-Year Cash to Debt Range
Min: 0.25   Max: No Debt
Current: 0.5

Equity to Asset 0.35
VOLC's Equity to Asset is ranked lower than
52% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. VOLC: 0.35 )
VOLC' s 10-Year Equity to Asset Range
Min: -0.89   Max: 0.88
Current: 0.35

-0.89
0.88
F-Score: 4
Z-Score: 1.09
M-Score: -2.32
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -7.37
VOLC's Operating margin (%) is ranked higher than
57% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 6.93 vs. VOLC: -7.37 )
VOLC' s 10-Year Operating margin (%) Range
Min: -25.38   Max: 7.4
Current: -7.37

-25.38
7.4
Net-margin (%) -9.99
VOLC's Net-margin (%) is ranked higher than
56% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 5.11 vs. VOLC: -9.99 )
VOLC' s 10-Year Net-margin (%) Range
Min: -64.36   Max: 11.09
Current: -9.99

-64.36
11.09
ROE (%) -11.39
VOLC's ROE (%) is ranked higher than
56% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 5.73 vs. VOLC: -11.39 )
VOLC' s 10-Year ROE (%) Range
Min: -21.58   Max: 12.42
Current: -11.39

-21.58
12.42
ROA (%) -4.51
VOLC's ROA (%) is ranked higher than
60% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 3.49 vs. VOLC: -4.51 )
VOLC' s 10-Year ROA (%) Range
Min: -165.23   Max: 8.21
Current: -4.51

-165.23
8.21
ROC (Joel Greenblatt) (%) -13.96
VOLC's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 394 Companies
in the Global Medical Devices industry.

( Industry Median: 12.42 vs. VOLC: -13.96 )
VOLC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -132.71   Max: 19.72
Current: -13.96

-132.71
19.72
Revenue Growth (%) 9.50
VOLC's Revenue Growth (%) is ranked higher than
82% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. VOLC: 9.50 )
VOLC' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 20.2
Current: 9.5

0
20.2
EBITDA Growth (%) -54.50
VOLC's EBITDA Growth (%) is ranked higher than
50% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: -1.20 vs. VOLC: -54.50 )
VOLC' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: -7.3
Current: -54.5

» VOLC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

VOLC Guru Trades in Q3 2013

Mariko Gordon 2,592,784 sh (+6.94%)
Paul Tudor Jones Sold Out
Manning & Napier Advisors, Inc 4,804,985 sh (-5.57%)
Steven Cohen 393,400 sh (-49.73%)
Jim Simons 40,500 sh (-96.1%)
» More
Q4 2013

VOLC Guru Trades in Q4 2013

Steven Cohen 194,900 sh (unchged)
Jim Simons Sold Out
Steven Cohen Sold Out
Manning & Napier Advisors, Inc 4,663,127 sh (-2.95%)
Mariko Gordon 390,163 sh (-84.95%)
» More
Q1 2014

VOLC Guru Trades in Q1 2014

Steven Cohen 33,418 sh (New)
Mariko Gordon Sold Out
Manning & Napier Advisors, Inc 3,958,382 sh (-15.11%)
» More
Q2 2014

VOLC Guru Trades in Q2 2014

Manning & Napier Advisors, Inc 4,733,937 sh (+19.59%)
Steven Cohen 426,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with VOLC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mariko Gordon 2014-03-31 Sold Out 0.35%$19.33 - $23.22 $ 10.12-53%0
Mariko Gordon 2013-12-31 Reduce -84.95%2.38%$18.95 - $24.36 $ 10.12-54%390163
Mariko Gordon 2013-09-30 Add 6.94%0.18%$18.04 - $23.99 $ 10.12-52%2592784
Mariko Gordon 2013-06-30 New Buy2.1%$16.58 - $22.41 $ 10.12-47%2424563
George Soros 2011-12-31 Sold Out 0.03%$21.76 - $30.57 $ 10.12-58%0
George Soros 2011-09-30 Reduce -35.69%0.02%$26.22 - $33.51 $ 10.12-66%67200
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.70
VOLC's P/B is ranked higher than
85% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. VOLC: 1.70 )
VOLC' s 10-Year P/B Range
Min: 1.69   Max: 10.49
Current: 1.7

1.69
10.49
P/S 1.40
VOLC's P/S is ranked higher than
82% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. VOLC: 1.40 )
VOLC' s 10-Year P/S Range
Min: 0.68   Max: 6.89
Current: 1.4

0.68
6.89
EV-to-EBIT -24.84
VOLC's EV-to-EBIT is ranked higher than
64% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 34.56 vs. VOLC: -24.84 )
VOLC' s 10-Year EV-to-EBIT Range
Min: -2321.6   Max: 142
Current: -24.84

-2321.6
142
Current Ratio 4.00
VOLC's Current Ratio is ranked higher than
81% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. VOLC: 4.00 )
VOLC' s 10-Year Current Ratio Range
Min: 1.49   Max: 9.25
Current: 4

1.49
9.25
Quick Ratio 3.26
VOLC's Quick Ratio is ranked higher than
82% of the 395 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. VOLC: 3.26 )
VOLC' s 10-Year Quick Ratio Range
Min: 1.01   Max: 8.31
Current: 3.26

1.01
8.31

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 17.75
VOLC's Price/Tangible Book is ranked higher than
56% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 6.00 vs. VOLC: 17.75 )
VOLC' s 10-Year Price/Tangible Book Range
Min: 2.62   Max: 30.89
Current: 17.75

2.62
30.89
Price/DCF (Projected) 5.22
VOLC's Price/DCF (Projected) is ranked higher than
79% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 456.50 vs. VOLC: 5.22 )
VOLC' s 10-Year Price/DCF (Projected) Range
Min: 4.64   Max: 15.1
Current: 5.22

4.64
15.1
Price/Median PS Value 0.34
VOLC's Price/Median PS Value is ranked higher than
97% of the 418 Companies
in the Global Medical Devices industry.

( Industry Median: 1.13 vs. VOLC: 0.34 )
VOLC' s 10-Year Price/Median PS Value Range
Min: 0.19   Max: 1.66
Current: 0.34

0.19
1.66
Earnings Yield (Greenblatt) -4.00
VOLC's Earnings Yield (Greenblatt) is ranked higher than
58% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. VOLC: -4.00 )
VOLC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.7   Max: 2.4
Current: -4

0.7
2.4
Forward Rate of Return (Yacktman) -1.14
VOLC's Forward Rate of Return (Yacktman) is ranked higher than
71% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 1.44 vs. VOLC: -1.14 )
VOLC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -4.8   Max: -0.6
Current: -1.14

-4.8
-0.6

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:VQY.Germany
Volcano Corporation designs, develops, manufactures and commercializes a suite of intravascular ultrasound (IVUS) and functional measurement (FM) products that enhance the diagnosis and treatment of vascular and structural heart disease. The company is also developing ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters, Forward-Looking IVUS or FLIVUS systems and catheters and image-guided therapy products. The company's FM offerings include consoles and single-use pressure and flow guide wires used to measure the pressure and flow characteristics of blood around plaque enabling physicians to gauge the plaque's physiological impact on blood flow and pressure. The company's FM products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. Volcano's FM products consist of pressure and flow consoles and single-procedure disposable pressure and flow guide wires. The company's consoles are mobile, proprietary and high speed electronic systems with different functionalities and sizes designed and manufactured to process the signals received from only its guide wires. Volcano's IVUS products consist of ultrasound consoles, single-procedure disposable phased array and rotational IVUS imaging catheters and additional functionality options such as virtual histology (VH), IVUS tissue characterization and ChromaFlo stent apposition analysis. The company's IVUS consoles are marketed as stand-alone units or customized units that could be integrated into a variety of hospital-based interventional surgical suites called catheterization laboratories. The company's IVUS consoles have been designed to serve as a multi-modality platform for its phased array and rotational IVUS catheters, fractional flow reserve, or FFR, pressure wires and Medtronic's Pioneer reentry device. The s5 family of consoles, which became Volcano's primary console following its full commercial launch in July 2006, is smaller, lighter and less expensive to manufacture, and has enhanced functionality. The company's IVUS products incorporate key features that add valuable clinical functionality addressing a number of the historical limitations of conventional IVUS and it intend to incorporate additional functionality in the future. Volcano's manufacturing facility is located in Rancho Cordova, California, where it produces IVUS consoles, FM consoles, IVUS catheters and FM guide wires. The company's console manufacturing strategy is to use third-party manufacturing partners to produce circuit boards and mechanical sub-assemblies.
» More Articles for VOLC

Headlines

Articles On GuruFocus.com
Weekly 3-Year Low Highlights: CHT, NE, HL, VOLC Sep 21 2014 
Who Is Mariko Gordon? A Guru to Follow Aug 30 2013 
Weekly Guru Bargains Highlights: GOLD, GFI, SAPMY, APPL, VOLC May 20 2013 
Weekly Guru Bargains Highlights: VOLC, SAPMY, BVN, NEM, TFM May 13 2013 
Weekly Guru Bargains Highlights: GOLD, NEM, ABX, VOLC, GFI May 06 2013 
Weekly 3-Year Low Highlights: PACT, ATI, VLY, VOLC Apr 28 2013 
Weekly Guru Bargains Highlights: AAPL, AEM, VOLC, ABX, TFM Apr 28 2013 
Volcano Corp. (VOLC) President & CEO R Scott Huennekens sells 37,500 Shares Mar 08 2011 
Volcano Corp. (VOLC) CFO John T Dahldorf sells 1,724 Shares Mar 01 2011 
Volcano Corp. (VOLC) President & CEO R Scott Huennekens sells 5,851 Shares Mar 01 2011 

More From Other Websites
Volcano Corporation Schedules Third Quarter Conference Call, Webcast Oct 29 2014
Volcano Corporation Schedules Third Quarter Conference Call, Webcast Oct 29 2014
Volcano Corp Banks on IVUS Portfolio amid Several Odds Oct 13 2014
U.S. equities finish mixed Oct 02 2014
[$$] Camber Capital Says Volcano Shares Undervalued Oct 02 2014
VOLCANO CORP Files SEC form 8-K/A, Financial Statements and Exhibits Sep 30 2014
[$$] Engaged Capital Calls for Volcano to Sell Itself Sep 29 2014
Volcano Issues Statement Regarding Letter From Engaged Capital Sep 29 2014
Engaged Capital Sends Letter to the Board of Volcano Corporation Sep 29 2014
Volcano to Showcase Two Novel Commercial Products at TCT 2014: SyncVision®, and the iFR® Modality Sep 12 2014
Studies Support Growing Use Of New Technology To Improve Stenting Sep 02 2014
Volcano Corporation Presentation At Morgan Stanley Conference To Be Webcast Sep 02 2014
VOLCANO CORP Financials Aug 15 2014
3 Stocks Rising on Unusual Volume Aug 14 2014
Volcano Corporation (VOLC) in Focus: Stock Tanks 20.4% Aug 11 2014
VOLCANO CORP Files SEC form 10-Q, Quarterly Report Aug 08 2014
Markets Up As Russia Seeks To End Military Activity Near Ukraine Aug 08 2014
3 Stocks Pushing The Health Care Sector Lower Aug 08 2014
Sotheby's Slips On Downbeat Earnings; NVIDIA Shares Surge Aug 08 2014
Midday movers: Allergan, McDonald's, Sotheby's & More Aug 08 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK